In a significant ruling that could reshape how pharmaceutical companies protect their brand names, Bombay High Court has stepped in to support Sun Pharmaceutical Industries Ltd. in a high stakes trademark dispute, case revolves around two similar sounding drug brands: RACIRAFT (owned by Sun Pharma) and ESIRAFT (used by Ahmedabad based Meghmani Lifesciences Ltd.).
Bombay High Court slams police harassment of doctors over minor girl MTP confidentiality. Statewide circular ordered to respect privacy in reproductive healthcare cases
Read MoreThe recent Bombay High Court ruling in the case of Glamstone Cosmetics Pvt. Ltd. v. Union of India (Writ Petition No. 957 of 2026, decided on March 9, 2026) has sent a clear message to importers of cosmetics and related products in India: regulatory compliance cannot be bypassed, even if the goods are not destined for the domestic market.
Read MoreThe Bombay High Court ruled that a disability certificate issued by any qualified medical practitioner is valid under the Employees’ Compensation Act, even if the doctor did not treat the injured worker. The Court emphasized that claims cannot be rejected solely because the certificate is from a non treating doctor, reinforcing the welfare objective of the Act.
Read More
